InnoLink Capital

InnoLink Capital is a specialized private equity and venture capital firm primarily focused on the life sciences, biotechnology, and healthcare technology sectors. The firm specializes in early-stage and growth-stage investments in innovative companies developing high-potential biopharmaceuticals, medical devices, and digital health solutions. InnoLink Capital is particularly notable for its strategic investments in major Chinese biotech success stories such as InnoCare Pharma, RemeGen, and MabPlex, where it has provided critical capital and industry expertise to advance clinical pipelines. With a strong presence in the Asian and North American markets, the firm leverages its deep industry network and strategic advisory capabilities to support transformative healthcare innovations from discovery through commercialization.